H.C. Wainwright analyst Yi Chen lowered the firm’s price target on BioLife Solutions (BLFS) to $27 from $29 and keeps a Buy rating on the shares post the Q3 report. The company’s divestiture is completed for all freezer and related businesses, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLFS:
- BioLife Solutions (BLFS) Makes Promising Strategic Pivot
- BioLife Solutions announces $6.1M sale of freezer subsidiary, Arctic Solutions
- BioLife Solutions price target raised to $32 from $30 at Craig-Hallum
- BioLife Solutions price target raised to $30 from $28 at Lake Street
- BioLife Solutions price target raised to $31 from $28 at TD Cowen